Piper Sandler Maintains Overweight on Braze, Lowers Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Brent Bracelin maintains an Overweight rating on Braze (NASDAQ:BRZE) but lowers the price target from $51 to $40.
October 10, 2024 | 9:08 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained its Overweight rating on Braze but has reduced the price target from $51 to $40, indicating a more cautious outlook.
The reduction in the price target from $51 to $40 suggests that the analyst sees less upside potential in the stock, which could lead to a negative short-term impact on the stock price. However, the maintained Overweight rating indicates continued confidence in the company's long-term prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100